Comments
Loading...
Orientation et prévision
Novo Nordisk publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/06/2025 | NVO | Novo Nordisk | FY | 2025 | — | — | — | $46.33B | $48.98B | $48.18B | |
05/07/2025 | NVO | Novo Nordisk | FY | 2025 | — | — | — | $45.02B | $47.47B | $51.98B | |
02/05/2025 | NVO | Novo Nordisk | FY | 2025 | — | — | — | $49.44B | $53.60B | $47.64B | |
11/06/2024 | NVO | Novo Nordisk | FY | 2024 | — | — | — | $41.74B | $43.10B | $41.92B | |
08/07/2024 | NVO | Novo Nordisk | FY | 2024 | — | — | — | $40.55B | $42.56B | $42.86B | |
05/02/2024 | NVO | Novo Nordisk | FY | 2024 | — | — | — | $40.25B | $42.96B | $41.28B | |
01/31/2024 | NVO | Novo Nordisk | FY | 2024 | — | — | — | $39.21B | $41.90B | $40.17B | |
11/02/2023 | NVO | Novo Nordisk | FY | 2023 | — | — | — | $33.07B | $34.62B | $31.83B | |
08/10/2023 | NVO | Novo Nordisk | FY | 2023 | — | — | — | $31.29B | $32.84B | $32.04B | |
05/04/2023 | NVO | Novo Nordisk | FY | 2023 | — | — | — | $30.09B | $31.63B | $31.90B | |
02/01/2023 | NVO | Novo Nordisk | FY | 2023 | — | — | — | $26.76B | $28.18B | $28.77B | |
11/02/2022 | NVO | Novo Nordisk | FY | 2022 | — | — | — | $23.66B | $24.23B | $22.97B | |
08/03/2022 | NVO | Novo Nordisk | FY | 2022 | — | — | — | $22.59B | $23.40B | $23.52B | |
02/02/2022 | NVO | Novo Nordisk | FY | 2022 | — | — | — | $24.04B | $24.90B | $22.48B | |
10/29/2021 | NVO | Novo Nordisk | Q3 | 2021 | — | — | — | $5.64B | $5.64B | $5.35B | |
10/29/2021 | NVO | Novo Nordisk | FY | 2021 | — | — | — | $22.55B | $23.15B | $21.35B | |
08/04/2021 | NVO | Novo Nordisk | FY | 2021 | — | — | — | $21.80B | $22.42B | $21.47B | |
02/03/2021 | NVO | Novo Nordisk | FY | 2021 | — | — | — | $21.35B | $22.17B | $21.76B |
FAQ
Quelles sont les dernières directives pour Novo Nordisk (NVO) ?
Il n'y a eu aucune orientation spécifique sur les ventes ou les bénéfices rapportée pour Novo Nordisk ces derniers mois.
Parcourir guidance et prévisions sur toutes les actions.